Yaron Werber
Stock Analyst at TD Cowen
(2.46)
# 2,405
Out of 5,154 analysts
43
Total ratings
43.75%
Success rate
3.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LEGN Legend Biotech | Downgrades: Hold | $62 → $21 | $18.97 | +10.70% | 3 | Jan 22, 2026 | |
| VOR Vor Biopharma | Initiates: Buy | n/a | $15.12 | - | 1 | Dec 17, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $86 → $75 | $21.25 | +252.94% | 3 | Nov 5, 2025 | |
| EXEL Exelixis | Maintains: Buy | $44 → $51 | $41.55 | +22.76% | 3 | Nov 5, 2025 | |
| ARGX argenx SE | Maintains: Buy | $800 → $1,146 | $717.79 | +59.66% | 4 | Oct 31, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $59 → $99 | $74.04 | +33.71% | 2 | Oct 30, 2025 | |
| ALEC Alector | Downgrades: Hold | n/a | $2.00 | - | 1 | Oct 22, 2025 | |
| IOBT IO Biotech | Downgrades: Hold | n/a | $0.30 | - | 2 | Sep 30, 2025 | |
| ONC BeOne Medicines AG | Reiterates: Buy | $334 | $301.12 | +10.92% | 1 | Apr 24, 2025 | |
| FBRX Forte Biosciences | Initiates: Buy | n/a | $28.76 | - | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $65.20 | - | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $28.78 | - | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $153 | $240.65 | -36.42% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $132 → $122 | $101.50 | +20.20% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $7.66 | - | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $35.48 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.38 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.33 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $29.43 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $8.87 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $27.06 | +40.43% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $28.78 | - | 1 | Oct 26, 2021 |
Legend Biotech
Jan 22, 2026
Downgrades: Hold
Price Target: $62 → $21
Current: $18.97
Upside: +10.70%
Vor Biopharma
Dec 17, 2025
Initiates: Buy
Price Target: n/a
Current: $15.12
Upside: -
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $86 → $75
Current: $21.25
Upside: +252.94%
Exelixis
Nov 5, 2025
Maintains: Buy
Price Target: $44 → $51
Current: $41.55
Upside: +22.76%
argenx SE
Oct 31, 2025
Maintains: Buy
Price Target: $800 → $1,146
Current: $717.79
Upside: +59.66%
Ionis Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $59 → $99
Current: $74.04
Upside: +33.71%
Alector
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.00
Upside: -
IO Biotech
Sep 30, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.30
Upside: -
BeOne Medicines AG
Apr 24, 2025
Reiterates: Buy
Price Target: $334
Current: $301.12
Upside: +10.92%
Forte Biosciences
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $28.76
Upside: -
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $65.20
Upside: -
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $28.78
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $240.65
Upside: -36.42%
Nov 6, 2024
Maintains: Hold
Price Target: $132 → $122
Current: $101.50
Upside: +20.20%
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $7.66
Upside: -
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $35.48
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.38
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $5.33
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $29.43
Upside: -
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $8.87
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $27.06
Upside: +40.43%
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $28.78
Upside: -